Biomoda Joins Lung Cancer Advocates To Call For Research Funding And Early Detection
2/11/2011
The chief executive officer of cancer diagnostics company Biomoda, Inc. (OTC BB: BMOD) will join lung cancer survivors on a series of nationally syndicated business radio talk shows to discuss the company's innovative technology, funding for lung cancer research and the importance of early detection...
EU Initiative In Research Into Living Cancer Cells In Time And Space
2/11/2011
New technology has made it possible to examine living cells in a microscope while at the same time collecting information that can be used to create mathematical models of the cells' behaviour - a new field of research known as 'systems microscopy'...
Sweeping View Of Prostate Cancer Genome Yields Deep Insights
2/10/2011
For the first time, researchers have laid bare the full genetic blueprint of multiple prostate tumors, uncovering alterations that have never before been detected and offering a deep view of the genetic missteps that underlie the disease...
EU Cancer Deaths Over One Million In 2011; Women's Lung Cancer On Rise
2/09/2011
It has been predicted that Europe in particular will witness close to 1.3 million cancer related deaths this year, with rates rising dramatically for lung cancer in women. Meanwhile, in a survey conducted by the British Medical Journal this month, 72% of readers think healthcare in England in five years' time will be worse or much worse compared with now...
Gene Test Could Solve Prostate Cancer Riddle And Spare Thousands From Surgery
2/09/2011
A genetic pattern could predict how aggressive prostate cancer is before treatment, and whether the disease will come back in men who have already been treated, according to research published1 in the Lancet Oncology...
The Hitch In The Drug? The Itch In The Drug
2/09/2011
Scratching deep beneath the surface, a team of researchers from the University of California, San Diego School of Medicine and three South Korean institutions have identified two distinct neuronal signaling pathways activated by a topical cream used to treat a variety of skin diseases. One pathway produces the therapeutic benefit; the other induces severe itching as a side effect...
Insufficient Sleep Found To Be A New Risk Factor For Colon Cancer
2/09/2011
An inadequate amount of sleep has been associated with higher risks of obesity, heart disease, diabetes, and death. Now colon cancer can be added to the list. In a ground-breaking new study published in the Feb...
Dutasteride Not A Cost-Effective Way To Prevent Prostate Cancer In Some Men
2/09/2011
The popular drug dutasteride may not be a cost-effective way to prevent prostate cancer in men who are at elevated risk of developing the disease, according to findings by a UT Southwestern Medical Center researcher...
Third Phase III Study Of Avastin-Based Regimen Met Primary Endpoint In Ovarian Cancer
2/09/2011
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that OCEANS, a Phase III study evaluating Avastin® (bevacizumab) in combination with chemotherapy (carboplatin and gemcitabine) followed by continued use of Avastin alone until disease progression in women with previously treated (recurrent), platinum-sensitive ovarian cancer, met its primary endpoint...
Avastin Proven To Battle Ovarian Cancer With Some Success
2/08/2011
A new Avastin study in recurrent, platinum-sensitive ovarian cancer showed women lived significantly longer without their disease getting worse. Bevacizumab (trade name Avastin) is a humanized monoclonal antibody that recognizes and blocks vascular endothelial growth factor A...